John Paul DeJoria's Schedule 13G Filing for Telomir Pharmaceuticals

John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust and in his individual capacity, filed a Schedule 13G with the SEC, disclosing beneficial ownership of 1,774,900 shares of Telomir Pharmaceuticals, Inc. common stock, representing 5.50% of the total shares. The filing indicates that the shares were not acquired for the purpose of influencing control of the issuer. The filing was made under Rule 13d-1(c) and includes a Limited Power of Attorney appointing Matthew R. Bair and Mate Zgombic as attorneys-in-fact for securities filings.